Evidence map›Paper›PMID 38230817›Full record

ArticleJournal of the National Cancer Institute2024

Response to Omoleye, Esserman, Olufunmilayo.

Karla Kerlikowske, Weiwei Zhu, Yu-Ru Su, Brian L Sprague, Ellen S O'Meara, Anna N A Tosteson, Karen J Wernli, Diana L Miglioretti

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the National Cancer Institute, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Karla KerlikowskeDepartments of Medicine and Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.ORCID 0000-0001-8793-8779
Weiwei ZhuKaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, WA, USA.
Yu-Ru SuKaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, WA, USA.
Brian L SpragueDepartments of Surgery and Radiology, University of Vermont, Burlington, VT, USA.
Ellen S O'MearaKaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, WA, USA.
Anna N A TostesonThe Dartmouth Institute for Health Policy and Clinical Practice and Dartmouth Cancer Center, Dartmouth Geisel School of Medicine, Lebanon, NH, USA.
Karen J WernliKaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, WA, USA.
Diana L MigliorettiDepartment of Public Health Sciences, University of California, Davis, Davis, CA, USA.

Funding

Risk-based Imaging Strategies to Improve Breast Cancer Surveillance OutcomesP01CA154292 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KARLA M KERLIKOWSKE · 2011 to 2026
$52.9M
Vermont Screening Process Documentation UnitU54CA163303 · NCI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI SPRAGUE, BRIAN L · 2011 to 2017
$6.4M
AHRQ HHS R01 HS018366NCI NIH HHS P01 CA154292NCI NIH HHS P01CA154292NCI NIH HHS U54 CA163303Patient-Centered Outcomes Research Institute PCS-1504-30370
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38230817
PMCPMC10995845

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.